Is Being a "Disruptor" Still a Good Thing? A Look at the 2026 Healthcare Disruptors List

Why It Matters

Understanding which forces truly disrupt healthcare helps investors allocate capital wisely and enables providers to prepare for labor, policy, and public‑health challenges that could reshape service delivery.

Key Takeaways

• ARP added for political lobbying and massive senior consumer base.
• Direct-to-consumer primary care gains VC funding but faces margin challenges.
• Vaccine hesitancy re‑emerges as a negative disruptor impacting capacity.
• Healthcare unions intensify strikes, threatening staffing and cost stability.
• Disruptor label now split between genuine innovation and hype‑driven ideas.

Summary

The episode examines Alan Schubbridge’s 2026 Healthcare Disruptors List, probing why certain players were added, removed, or placed in a "waiting room" category. Schubbridge, a veteran marketer at Providence, uses the list as a conversation starter about which innovations truly reshape care and which are merely hype. Key insights include the addition of the American Rescue Plan (ARP) for its lobbying power and senior‑consumer influence, and the rise of direct‑to‑consumer primary‑care models buoyed by venture capital despite thin margins. CVS was dropped, while Best Buy Health and Salesforce linger in a holding pattern, reflecting uncertainty about their long‑term impact. Vaccine hesitancy re‑appears as a "negative disruptor," and healthcare unions, especially SEIU, are highlighted for escalating labor actions. Schubbridge emphasizes that "disruption isn’t just hype" and warns that vaccine hesitancy is a "negative disruption" straining resources. He notes ARP’s policy work and DTC primary care’s funding surge, yet cautions on sustainability given poor primary‑care economics. The discussion also underscores how unions can destabilize staffing and cost structures. For investors and providers, the list signals that the "disruptor" tag no longer guarantees success; due diligence must separate genuine, financially viable change from fleeting buzz. Anticipating labor unrest and addressing vaccine‑preventable disease spikes will be critical for maintaining capacity and profitability in 2026 and beyond.

Original Description

Big Tech Hype Meets the Reality of Patient Care.

Claiming you will fix healthcare overnight guarantees failure. Real influence comes from the organizations doing the hard work on the front lines.

Alan Shoebridge, AVP & Chief Communication Officer (National) at Providence, joins Healthcare IT Today to break down his 2026 Disruptors List. He shares the reasons why giants like AARP made the cut and why past heavyweights like CVS are no longer considered disruptors. You will get a clear look at which trends actually matter and which ones are just noise.

🔔 Subscribe for more great interviews with Health IT leaders.

Connect with Alan Shoebridge on LinkedIn: https://www.linkedin.com/in/shoebridge/

Find more great health IT content at https://www.healthcareittoday.com/

---------

⏰ Jump to the Moments That Matter

0:00 The 2026 Disruptors List Explained

3:46 Separating Real Impact from Silliness

5:34 Why AARP Has Massive Influence

7:26 The Reality of Direct to Consumer Primary Care

10:18 Vaccine Hesitancy Returns as a Major Threat

15:24 The Hubris That Kicked CVS Off the List

19:06 Best Buy Health and the Waiting Room

21:01 Hoping Congress Steps Up for Providers

#HealthIT #DigitalHealth #PatientEngagement #HealthTech #HITsm